Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.731 USD | +7.01% | -2.64% | -48.16% |
03-27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
03-26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 0.9051 | 1.080 | 1.160 |
Spread/Res. | -19.24% | -32.31% | -36.98% |
Spread/Supp. | +9.09% | +9.09% | +22.84% |
Support | 0.6701 | 0.6701 | 0.5951 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LUCD Stock
- Charts Lucid Diagnostics Inc.